Epinephrine (L-adrenaline) is a bulk active pharmaceutical ingredient used to manufacture or compound prescription products.
Spectrum Laboratory Products is voluntarily recalling three lots of epinephrine (L-adrenaline), a bulk active pharmaceutical ingredient (API) used to manufacture or compound prescription products. Customer complaints have found the product to be discolored.
Epinephrine (L-adrenaline) bulk API powder is used in manufacturing and compounding of epinephrine prescription products, which are used to treat patients with anaphylaxis and other severe immediate hypersensitivity reactions. The use of a finished dose product manufactured or compounded with this recalled product could result in less-effective product.
Spectrum Laboratory Products has not received any reports of adverse events related to this recall.
Epinephrine (L-adrenaline) is packaged in amber glass bottles enclosed in a vacuum sealed pouch. It can be identified by the Spectrum catalog number EP130, and it was distributed directly from facilities nationwide in the United States and to Canada.
The affected lots include:
NDC numbers of the impacted products and package size can be found here.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
August 2nd 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
August 2nd 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More